Key points are not available for this paper at this time.
FD-OCT is safe in an unselected and heterogeneous group of patients with varying clinical settings.
Sijde et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: